Direxion Daily S&P Biotech Bull 3X ETF
LABU
LABU
33 hedge funds and large institutions have $56.7M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18% less funds holding
Funds holding: 40 → 33 (-7)
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
Holders
33
Holding in Top 10
–
Calls
$185M
Puts
$156M
Top Buyers
| 1 | +$9.13M | |
| 2 | +$5.2M | |
| 3 | +$3.26M | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$2.35M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.12M |
Top Sellers
| 1 | -$3.65M | |
| 2 | -$2.15M | |
| 3 | -$1.67M | |
| 4 |
Morgan Stanley
New York
|
-$1.01M |
| 5 |
TSS
Two Sigma Securities
New York
|
-$905K |
